http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010141846-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-802 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0057 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-08 |
| filingDate | 2008-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010141846-A |
| titleOfInvention | MEDICAL PRODUCT FOR TREATMENT OF OBSTRUCTIONS OF ORGANISM LIGHTINGS AND FOR PREVENTION OF THREATENING REPEATED OBTURATIONS |
| abstract | 1. The use of citric acid ester and anti-inflammatory, cytostatic, cytotoxic, antiproliferative, anti-microtubular, anti-angiogenic, anti-restenotic (anti-restenotic), anti-fungicidal, anti-neoplastic, anti-migration, atrombogenic or anti-thrombogenic active substances for coating a catheter balloon. ! 2. The use according to claim 1, in which the citric acid ester is acetyl tributyl citrate or acetyl triethyl citrate or a compound of the following structure:! ! where R, R 'and R "independently from each other mean a hydrogen atom or a linear or branched, saturated or unsaturated, substituted by at least one functional group or unsubstituted alkyl radical, an arylalkyl radical or cycloalkyl radical. ! 3. The use according to claim 1, in which the citric acid ester is a representative from the group consisting of triethyl citrate, acetyl triethyl citrate, tributyl citrate and acetyl tributyl citrate. ! 4. The use according to claim 1, in which at least one anti-inflammatory, cytostatic, cytotoxic, antiproliferative, antimycrotubular, anti-angiogenic, anti-restenotic (anti-restenosis), anti-fungicidal, anti-neoplastic, anti-migratory, atrombogenic or antithrombogenic active substances is pacific. ! 5. A catheter balloon coated with at least one anti-inflammatory, cytostatic, cytotoxic, antiproliferative, antimycrotubular, anti-angiogenic, anti-restenotic (anti-restenotic), anti-fungicidal, anti-neoplastic, anti-immigration, atrombogenic or anti |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2766047-C2 |
| priorityDate | 2007-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.